【摘 要】
:
Metal-organic framework (MOF) membranes hold great promise in energy-efficient chemical separa-tions.The outstanding challenges of the microstructural design stem from (1) thinning of membranes to immensely reduce the mass-transfer resistance (for high pe
【机 构】
:
State Key Laboratory of Catalysis,Dalian Institute of Chemical Physics,Chinese Academy of Sciences,D
论文部分内容阅读
Metal-organic framework (MOF) membranes hold great promise in energy-efficient chemical separa-tions.The outstanding challenges of the microstructural design stem from (1) thinning of membranes to immensely reduce the mass-transfer resistance (for high permeances);(2) tuning of orientation to optimize the selective transport of gas molecules,and (3) reinforcement of intercrystalline structure to subside leakage through defective gaps (for high selectivity).Here,we propose the ZIF-L membrane that is completely confined into the voids of the alumina support through an interfacial assembly process,producing an appealing membrane-interlocked-support (MIS) composite architecture that meets the requirements of the microstructural design of MOF membranes.Consequently,the membranes show average H2 permeances of above 4000 GPU and H2/CO2 separation factor (SF) of above 200,representing record-high separation performances of ZIF-L membranes and falling into the industrial target zone (H2 permeance > 1000 GPU and H2/CO2 SF > 60).Furthermore,the ZIF-L membrane possessing the MIS com-posite architecture that is established with alumina particles as scaffolds shows mechanical stability,scraped repeatedly by a piece of silicon rubber causing no selectivity loss.
其他文献
目的 探讨CXCR2拮抗剂通过减少中性粒细胞迁移并抑制中性粒细胞胞外诱捕网(neutrophil extracellular traps,NETs)形成对实验性自身免疫性脑脊髓炎(experimental autoimmune encephalomyelitis,EAE)的保护作用.方法 用髓鞘少突胶质细胞糖蛋白35-55 (myelin oligodendrocyte glycoprotein35-55,MOG35-55)诱导建立多发性硬化症(multiple sclerosis,MS)的小鼠疾病模型E
目的 提取、分离部分天然细菌脂肽,系统考察天然细菌脂肽的佐剂活性.方法 选取耐甲氧西林金黄色葡萄球菌(Methicillin-resistant Staphylococcus aureus)、表皮葡萄球菌(Staphylococcus epidermidis)、铜绿假单胞菌(Pseudomonas aeruginosa)、肺炎链球菌(Streptococcus pneumoniae)、化脓性链球菌(Streptococcus pyogenes)和变形链球菌(Streptococcus mutans)共6种
目的 探讨TRIM58在脂多糖(lipopolysaccharide,LPS)诱导的足细胞损伤中的作用及其分子机制.方法 将体外培养的永生化人足细胞分成4组:正常对照组(Control),LPS刺激组(LPS),TRIM58过表达+LPS组(OE-TRIM58+LPS),空载体+LPS组(OE-NC+LPS).通过ELISA检测炎性分子IL-1β、TNF-α的表达;通过real-time PCR、Western blot、免疫荧光检测足细胞Desmin、ZO-1的表达;通过Transwell检测足细胞迁移
The essential trace element iron regulates a wide range of biological processes in virtually all living organisms.Because both iron deficiency and iron overload can lead to various pathological conditions,iron homeostasis is tightly regulated,and understa
The interplay between quenched disorder and critical behavior in quantum phase transitions is concep-tually fascinating and of fundamental importance for understanding phase transitions.However,it is still unclear whether or not the quenched disorder infl
Chiglitazar(Carfloglitazar)is a novel non-thiazolidinedione(TZD)structured peroxisome proliferator-activated receptor(PPAR)pan-agonist that has shown promising effects on glycemic control and lipid regulation in patients with type 2 diabetes in previous c
目的 研究nexilin F-肌动蛋白结合蛋白(NEXN)基因表达与结直肠癌患者预后及免疫细胞浸润的相关性.方法 利用Oncomine数据库分析NEXN基因在肿瘤和正常组织中的表达差异;通过Prognoscan数据库分析NEXN基因表达与结直肠癌患者预后的关系;通过TIMER及GEPIA数据库分析NEXN基因高表达与免疫浸润的相关性.结果 Oncomine数据库分析结果表明NEXN在结直肠癌中高表达(fold change=3.057,P<0.0001);Prognoscan数据库GSE17536和GSE
目的 检测Notch受体和配体在甲型H1N1流感患者中的表达,观察Notch信号通路对甲型H1N1流感病毒特异性CD8+T细胞的调控作用.方法 本研究入组轻症甲型H1N1流感患者27例、重症甲型H1N1流感患者11例和健康对照者18例.实时定量PCR法检测外周血单个核细胞(PBMC)中Notch受体和配体mRNA的相对表达量.PBMC与Notch信号通路抑制剂DAPT刺激培养24 h后,流式细胞术检测病毒特异性CD8+T细胞分泌肿瘤坏死因子-α(TNF-α)和干扰素-γ(IFN-γ)的变化,酶联免疫斑点试
Chiglitazar(Carfloglitazar)is a novel peroxisome proliferator-activated receptor(PPAR)pan-agonist that has shown promising effects on glycemic control and lipid regulation in patients with type 2 diabetes.In this randomized phase 3 trial,we compared the e
With the current limited drug therapy for the core symptoms of autism spectrum disorder(ASD),we herein report a randomized,double-blind,placebo-controlled trial to investigate the efficacy,safety,and potential neural mechanism of bumetanide in children wi